ABO and Rhesus blood groups and multiple health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies

Fang-Hua Liu,Jia-Kai Guo,Wei-Yi Xing,Xue-Li Bai,Yu-Jiao Chang,Zhao Lu,Miao Yang,Ying Yang,Wen-Jing Li,Xian-Xian Jia,Tao Zhang,Jing Yang,Jun-Tong Chen,Song Gao,Lang Wu,De-Yu Zhang,Chuan Liu,Ting-Ting Gong,Qi-Jun Wu
DOI: https://doi.org/10.1186/s12916-024-03423-x
IF: 9.3
2024-05-23
BMC Medicine
Abstract:Numerous studies have been conducted to investigate the relationship between ABO and Rhesus (Rh) blood groups and various health outcomes. However, a comprehensive evaluation of the robustness of these associations is still lacking.
medicine, general & internal
What problem does this paper attempt to address?
### Problems the Paper Aims to Address This paper aims to comprehensively evaluate the relationship between the ABO blood group system and the Rh blood group system with various health outcomes. Although numerous studies have previously explored the relationship between these blood types and different health outcomes, there is currently a lack of studies that comprehensively evaluate the robustness of these associations. Specifically, this umbrella review systematically reviews existing systematic reviews and meta-analyses to assess the associations between ABO and Rh blood types and various health outcomes, and grades the strength and reliability of this evidence. ### Main Findings - **Type 2 Diabetes**: There is a significant association between blood type B and an increased risk of type 2 diabetes (Odds Ratio [OR] = 1.28; 95% Confidence Interval [CI]: 1.17, 1.40), classified as convincing evidence (Class I). - **Cancer**: Blood type A is associated with an increased risk of gastric cancer (OR = 1.11; 95% CI: 1.07, 1.15); blood type O is associated with a reduced risk of gastric cancer (OR = 0.91; 95% CI: 0.89, 0.94). - **Infectious Diseases**: Blood types A and B are associated with an increased risk of COVID-19 infection (ORs are 1.25 and 1.15, respectively), while blood type O is associated with a reduced risk of COVID-19 infection (OR = 0.88; 95% CI: 0.82, 0.94). - **Cardiovascular Diseases**: Blood type A is associated with an increased risk of myocardial infarction (OR = 1.29; 95% CI: 1.16, 1.45) and peripheral vascular disease (OR = 1.44; 95% CI: 1.19, 1.74). Through this approach, the researchers hope to provide reliable data for clinicians and policymakers to identify high-risk groups and guide clinical practice and guideline development.